Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Stanford University Medical Center, Palo Alto

Kaiser Permanente, Sacramento

Research and Education, Inc., San Diego

Kaiser Permanente San Francisco, San Francisco

Silicon Valley Research Institute, San Jose

The Queen's Medical Center, Honolulu

Digestive Disease Associates, PA, Baltimore

Tufts Medical Center, Boston

Icahn School of Medicine at Mount Sinai, New York

Xiaoli Ma, PC, Philadelphia

Virginia Commonwealth University, Richmond

Kaiser Permanente, Springfield

Gordon & Leslie Diamond Health Care Centre, Vancouver

Liver and Intestinal Research Center, Vancouver

University of Manitoba, Winnipeg

Toronto General Hospital-The University Health Network, Toronto

Toronto Liver Centre, Toronto

Toronto Western Hospital-The University Health Network, Toronto

Aou-S.Orsola-Malpighi - Universita Degli Studi Di, Bologna

Azienda Ospedaliero-Universitaria di Parma, Parma

Azienda Ospedaliero-Universitaria Pisana, Pisa

IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo

Auckland Clinical Studies, Auckland

Dr. Victor Babes Hospital for Infectious Diseases, Bucharest

Institutul National de Boli Infectioase Prof.Dr. Matei Bals, Bucharest

Kyungpook National University Hospital, Daegu

The Catholic University of Korea, Seocho

Seoul National University Bundang Hospital, Seongnam

Samsung Medical Center, Seoul

Seoul National University College of Medicine, Seoul

Yonsei Universiity, Seoul

Pusan National University Yangsan Hospital, Yangsan

The Catholic University of Korea, Yangsan